Hui Li

Beijing Health Guard Biotechnology, Inc. engages in the research, development, and industrialization of recombinant protein vaccines. It is involved in the development of HPV vaccines and multiple innovative candidate vaccines for other infectious diseases, such as a recombinant bivalent COVID-19 vaccine, a recombinant polyvalent nor virus vaccine, a recombinant RSV vaccine, and a recombinant zoster vaccine. The company was founded by Xiao Jiang Chen, Run Lin Ma and Yong Jiang Liu on April 14, 2008 and is headquartered in Beijing, China.